Literature DB >> 32197095

Measles eradication-retreating is not an option.

David N Durrheim1.   

Abstract

Measles eradication is biologically and technically feasible, but suboptimal immunisation programme performance, insufficient political commitment, overcautious global agencies, and inadequate prioritisation by important donors are hindering progress towards this noble public health goal. These constraints have given rise to a global resurgence in measles cases and preventable deaths, with re-established transmission in countries that have previously eliminated endemic virus transmission. The ethical, economic, and epidemiological reasons for accelerating progress towards eradication are irrefutable. Measles virus also serves as the most sensitive test of universal health coverage. Where health systems are not reaching all susceptible children and communities, the presence of measles cases will expose and proclaim this failure. The global health community should urgently intensify efforts to eradicate measles.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32197095     DOI: 10.1016/S1473-3099(20)30052-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  6 in total

1.  Accelerating measles elimination in the Western Pacific Region during the calm between the storms.

Authors:  David N Durrheim; Michael G Baker; Maria Rosario Capeding; Kee Tai Goh; Dukhyoung Lee; Mark Papania; Paul A Rota; Thian Lian Soo; Thomas H Tsang; Aiqiang Xu
Journal:  Lancet Reg Health West Pac       Date:  2022-05-31

2.  Prevalence of measles antibodies among migrant workers in Singapore: a serological study to identify susceptible population subgroups.

Authors:  Li Wei Ang; Qi Gao; Vernon Jian Ming Lee; Yee Sin Leo; Lin Cui; Aysha Farwin; Matthias Paul Han Sim Toh; Irving Charles Boudville; Mark I-Cheng Chen; Angela Chow; Raymond Tzer-Pin Lin
Journal:  BMC Infect Dis       Date:  2022-01-25       Impact factor: 3.090

3.  Trends of the Global, Regional, and National Incidence of Measles, Vaccine Coverage, and Risk Factors in 204 Countries From 1990 to 2019.

Authors:  Ruitong Wang; Wenzhan Jing; Min Liu; Jue Liu
Journal:  Front Med (Lausanne)       Date:  2022-01-20

Review 4.  Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective.

Authors:  Alvin Pumelele Ndondo; Brian Eley; Jo Madeleine Wilmshurst; Angelina Kakooza-Mwesige; Maria Pia Giannoccaro; Hugh J Willison; Pedro M Rodríguez Cruz; Jeannine M Heckmann; Kathleen Bateman; Angela Vincent
Journal:  Front Immunol       Date:  2022-03-09       Impact factor: 7.561

Review 5.  Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas.

Authors:  Pauline Samia; Katherine Oyieke; Dorcas Tunje; Anaita Udwadia-Hegde; Kristen Feemster; Ibrahim Oncel; Banu Anlar
Journal:  Curr Treat Options Neurol       Date:  2022-03-19       Impact factor: 3.972

6.  Social Media Sharing of Articles About Measles in a European Context: Text Analysis Study.

Authors:  Dominik Wawrzuta; Mariusz Jaworski; Joanna Gotlib; Mariusz Panczyk
Journal:  J Med Internet Res       Date:  2021-11-08       Impact factor: 5.428

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.